WeRide Gets Permit for Robotaxi Service in Beijing's Core Urban Area-March 2024-www.financetom.com

WeRide Gets Permit for Robotaxi Service in Beijing's Core Urban Area

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

WeRide Gets Permit for Robotaxi Service in Beijing's Core Urban Area

Mar 13, 2025 1:22 AM

03:48 AM EDT, 03/13/2025 (MT Newswires) -- WeRide ( WRD ) said late Wednesday it received approval to operate commercial robotaxi ride-hailing services between the Beijing Economic-Technological Development Area and Beijing South Railway Station.

WeRide ( WRD ) said it plans to expand its robotaxi service area in Beijing, with future operations targeting airports and high-speed railway stations.

Previous page： Temu, Shein targeted as EU cracks down on unsafe ecommerce imports Next page： Michelin sees possible impact on sourcing, investments from Trump tariffs

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Temu, Shein targeted as EU cracks down on unsafe ecommerce imports

Feb 5, 2025

BRUSSELS, Feb 5 (Reuters) - Chinese online marketplace Temu and fast-fashion retailer Shein will be liable for the sale of unsafe and dangerous products on their platforms, the European Commission said on Wednesday as part of a crackdown against the flood of cheap ecommerce imports into the European Union. The EU executive also said it would coordinate a joint investigation...

Michelin sees possible impact on sourcing, investments from Trump tariffs

Feb 5, 2025

(Reuters) - Michelin is assessing the impact from possible U.S. tariffs on Canada and Mexico but it is too early to estimate consequences from the levies on its supply chain and investments, the French tyre maker said on Wednesday. Most of the tyres Michelin sells in the United States are produced locally, a spokesperson for the company told Reuters, highlighting...

Novo Nordisk CEO: side-effects not a problem in CagriSema study

Feb 5, 2025

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk's CEO said on Wednesday side-effects were not a problem in the trial of its next-generation obesity drug candidate CagriSema as the company considers dosage escalation and trial length for a new study. The company on Dec. 20 revealed results in its late-stage study which were weaker than expected, wiping about $125 billion from...

Deals of the day-Mergers and acquisitions

Feb 5, 2025

Feb 5 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Wednesday: ** Private equity-backed broker King Risk Partners has acquired Dayton, Ohio-based Barker, Beck, Collins & Kronauge Agency (BBC&K), further extending its presence in the Midwest. ** Total Specific Solutions (TSS) has signed a deal to buy a further 14.84% stake in Polish...